Cerus Corporation (CERS) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Tue June 15th, 2021

- 19:42
  AnalysisCerus Corp.: Market Continues To Overlook Growth And Upside PotentialSeeking Alpha

Wed May 5th, 2021

- 14:28
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation (CERS) CEO Obi Greenman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha
- 13:30
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation (CERS) Q1 2021 Earnings Call TranscriptThe Motley Fool

Wed April 21st, 2021

- 10:03
  Press ReleasesCerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System™PR Newswire

Tue March 16th, 2021

- 19:43
  AnalysisCerus Corp.: Remaining Bullish Despite Delayed Compliance DateSeeking Alpha

Fri February 26th, 2021

- 15:01
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation (CERS) Q4 2020 Earnings Call TranscriptThe Motley Fool
- 00:52
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation's (CERS) CEO Obi Greenman on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Thu February 11th, 2021

- 13:03
  Press ReleasesCerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™PR Newswire

Wed December 16th, 2020

- 14:59
  AnalysisCerus Update: Tailwinds Now Include FDA Approval Of Cryoprecipitate ProductSeeking Alpha

Wed November 18th, 2020

- 13:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisCerus Faces Pipeline Of Calamities Going Into 2021Seeking Alpha

Fri October 30th, 2020

- 19:30
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation (CERS) Q3 2020 Earnings Call TranscriptThe Motley Fool
- 17:15
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCerus Corporation 2020 Q3 - Results - Earnings Call PresentationSeeking Alpha
- 02:41
  EarningsAnalysisCerus Corporation (CERS) CEO Obi Greenman on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Fri October 16th, 2020

- 07:29
  AnalysisCerus Inks FDA Contract, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Wed August 5th, 2020

- 06:01
  EarningsAnalysisCerus Corporation (CERS) Q2 2020 Earnings Call TranscriptThe Motley Fool
- 02:47
  EarningsAnalysisCerus Corporation (CERS) CEO Obi Greenman on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha

Tue August 4th, 2020

- 10:03
  Press ReleasesCerus Endovascular and Balt Enter Strategic Distribution Agreement for Innovative Neurovascular Devices to Treat a Range of Intracranial AneurysmsPR Newswire

Tue July 28th, 2020

- 10:03
  Press ReleasesCerus Endovascular Receives CE Mark Approval for its CerusEndo MC 021 MicrocatheterPR Newswire

SPY$395.63-6.2%

QQQ$315.85-8.5%

DOW$64.140.94%

--

SPY$395.63-6.2%

QQQ$315.85-8.5%

DOW$64.140.94%

--

About Developer Contact